WallStreetZenWallStreetZen

NASDAQ: ORKA
Oruka Therapeutics Inc Stock Ownership - Who owns Oruka Therapeutics?

Insider buying vs selling

Have Oruka Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Janus Henderson Group PLC10% Owner2024-08-16428$2.98
$1.27kBuy
Janus Henderson Group PLC10% Owner2024-08-165,390$2.93
$15.79kBuy
Janus Henderson Group PLC10% Owner2024-07-2530,227$3.05
$92.28kBuy
Janus Henderson Group PLC10% Owner2024-07-247,056$3.16
$22.28kBuy
Janus Henderson Group PLC10% Owner2024-07-24165,000$3.20
$528.00kBuy
Janus Henderson Group PLC10% Owner2024-07-2417,800$3.18
$56.59kBuy
Janus Henderson Group PLC10% Owner2024-07-1194,537$3.45
$326.34kBuy
Janus Henderson Group PLC10% Owner2024-07-1021,963$3.46
$76.06kBuy
Janus Henderson Group PLC10% Owner2024-07-1033,500$3.47
$116.08kBuy
Janus Henderson Group PLC10% Owner2024-07-0916,917$3.43
$58.09kBuy

1 of 2

ORKA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORKA insiders and whales buy or sell their stock.

ORKA Shareholders

What type of owners hold Oruka Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC1,282.77%15,507,760$387.54MInstitution
Forest Baskett845.50%10,221,465$255.43MInsider
Peter W. Sonsini845.50%10,221,465$255.43MInsider
Anthony A. Florence Jr.845.50%10,221,465$255.43MInsider
Ravi Viswanathan845.50%10,221,465$255.43MInsider
Scott D. Sandell845.50%10,221,465$255.43MInsider
David M. Mott845.50%10,221,465$255.43MInsider
Harry R. Weller845.50%10,221,465$255.43MInsider
Joshua Makower845.50%10,221,465$255.43MInsider
Jon Sakoda845.50%10,221,465$255.43MInsider

1 of 3

ORKA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORKA8.00%92.00%Net BuyingNet Buying
IMRX32.34%46.80%Net Selling
OCEA11.59%75.32%
ACXP7.43%14.80%Net Buying
NRBO3.13%96.87%Net BuyingNet Buying

Oruka Therapeutics Stock Ownership FAQ

Who owns Oruka Therapeutics?

Oruka Therapeutics (NASDAQ: ORKA) is owned by 1,068.72% institutional shareholders, 12,291.59% Oruka Therapeutics insiders, and 0.00% retail investors. Forest Baskett is the largest individual Oruka Therapeutics shareholder, owning 10.22M shares representing 845.50% of the company. Forest Baskett's Oruka Therapeutics shares are currently valued at $286.20M.

If you're new to stock investing, here's how to buy Oruka Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.